Emmaus Life Sciences Inc EMMA
$0.03 $0.01 (22.99%) 1D
Last Updated: Aug 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
EMMA Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Emmaus Life Sciences Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Emmaus Life Sciences Inc. Stock Analysis EMMA
United States Health Care Nano Cap Emmaus Life Sciences, Inc. engages in the discovery, development, marketing, and sale of treatments and therapies for rare and orphan diseases. The company is headquartered in Torrance, California and currently employs 32 full-time employees. The company went IPO on 2000-05-09. The firm is engaged in the discovery, development, marketing and sales of treatments and therapies, primarily for rare and orphan diseases. Its lead product, Endari (prescription grade L-glutamine oral powder) helps to reduce the acute complications of sickle cell disease (SCD) in adult and pediatric patients five years of age and older. Its product pipeline includes ELS001/ELS007, ELS004, ELS005, ELS003, and ELS002. The Company, through Kainos Medicine, Inc. (Kainos), has a license in the territory encompassing the United States, the United Kingdom, and the European Union to patent rights, know-how, and other intellectual property relating to Kainos’s IRAK4 inhibitor, referred to as KM10544, for the treatment of cancers, including leukemia, lymphoma, and solid tumor cancers. The firm has also developed chondrocyte and osteoblast cell sheets using human mesenchymal stem cells.
Emmaus Life Sciences Inc (EMMA) Chart
Financial Metrics & Statements of Emmaus Life Sciences Inc (EMMA)
FAQ's for Emmaus Life Sciences Inc (EMMA)
- As of August 2026, Emmaus Life Sciences Inc EMMA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Emmaus Life Sciences Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Emmaus Life Sciences Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Emmaus Life Sciences Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Emmaus Life Sciences Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Emmaus Life Sciences Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Emmaus Life Sciences Inc (EMMA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
